flow trial semaglutide trial: In participants with type 2 diabetes and chronic kidney disease, weekly treatment substantially reduced risks of heart failure events or cardiovascular death. https://t.co/SaGx7tf0ie #JACC #ESCCongress #HeartFailure #T2D #CKD Effects of Semaglutide on Heart

Sudden discontinuation of beta-blockers can lead to a dangerous rebound effect in heart rate and blood pressure

The decisions that will define GLP-1 outcomeswho prescribes, how care is coordinated, when to decline requests, and how to integrate lifestyle medicineare being made in exam rooms across the country

Antiapoptotic and antiautophagic effects of glial cell line-derived neurotrophic factor and hepatocyte growth factor after transient middle cerebral artery occlusion in rats

Novo Nordisks drug Wegovy is FDA-approved for weight loss in adults, while the companys drug Ozempic is approved to treat diabetes but is also prescribed off-label for weight loss

The combined nature of KLOW Blend makes it very valuable for research uses where multiple aspects of gut health need to be addressed simultaneously

Do whatever works for you, and that you can stick to long-term